CD133 Antigen as a Potential Marker of Melanoma Stem Cells: In Vitro and In Vivo Studies
Melanoma is the most dangerous type of skin cancer. Cancer stem cells (CSCs) are suspected to be responsible for the cancer recurrence and in the consequence for cancer therapy failure. CD133 is a potential marker for detection of melanoma CSCs. Experiments were performed on the B16-F10 mouse melano...
Saved in:
Main Authors: | Tomasz Kloskowski, Joanna Jarząbkowska, Arkadiusz Jundziłł, Daria Balcerczyk, Monika Buhl, Kamil Szeliski, Magdalena Bodnar, Andrzej Marszałek, Gerard Drewa, Tomasz Drewa, Marta Pokrywczyńska |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2020/8810476 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles—a new player in the development of urinary bladder cancer
by: Damian Kasiński, et al.
Published: (2025-01-01) -
CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma
by: Jiaojiao Xu, et al.
Published: (2025-01-01) -
Shell Model Calculations of Energy Levels and Binding Energy of 133;135Sn, and 133;135Sb Nuclei
by: Ruaa S. Abdullhussein
Published: (2022-03-01) -
Normal and melanoma skin visualized, quantified and compared by in vivo photoacoustic imaging
by: Terese von Knorring, et al.
Published: (2025-04-01) -
The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
by: Said A Al-Busafi, et al.
Published: (2012-01-01)